MS
CNST

Maven Securities’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Maven Securities’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-41,000
Closed -$1.39M – 1456
2021
Q2 		$1.39M Buy
+41,000
New +$1.04M 0.06% 329

Maven Securities's CNST Position: Q3 2021 in Review

Maven Securities sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 41,000 shares — an estimated $1.39M sold.

Maven Securities first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $1.39M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Maven Securities reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Maven Securities sold 41,000 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.39M.
  • Maven Securities first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Maven Securities's Constellation Pharmaceuticals, Inc. position peaked at $1.39M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Maven Securities's 13F filing for Q3 2021, filed 15 Nov 2021.